Treatment May Delay Earliest MS Events

(MedPage Today) -- BOSTON -- Treatment with teriflunomide (Aubagio), a drug approved for relapsing multiple sclerosis (MS), reduced the risk of a clinical event in people with radiologically isolated syndrome (RIS), the phase III TERIS trial...
Source: MedPage Today Neurology - Category: Neurology Source Type: news